Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;66(5):671-677.
doi: 10.1111/1754-9485.13371. Epub 2021 Dec 23.

Dosimetric comparison of high-dose rate cervix brachytherapy with and without interstitial needles and the impact on target volume coverage, and organ at risk constraints

Khadiga E Mohammed  1 , Tanisha Nagar  1 , Shelley M Pearson  1 , Jethro Donaldson  1 , Carol Johnson  1
Affiliations

Dosimetric comparison of high-dose rate cervix brachytherapy with and without interstitial needles and the impact on target volume coverage, and organ at risk constraints

Khadiga E Mohammed et al. J Med Imaging Radiat Oncol. 2022 Aug.

Abstract

Introduction: The aim of this audit was to compare the data from the Wellington Blood and Cancer Centre (WBCC) with international reported experience by quantifying the dosimetric impact of interstitial needles on target coverage and organ at risk (OAR) doses.

Methods: All patients identified as having had interstitial needles as part of their treatment out of a cohort of 120 radically treated cervical cancer patients between 2013 and 2019 were included. Each patient acted as their own control with two treatment plans optimised for each fraction; the clinically treated plan and a re-optimisation without the use of interstitial needles. Plan optimisation was completed according to the departmental protocol and cumulative equivalent doses for 2 Gy fractions (EQD2) were calculated.

Results: Eighteen patients were suitable for evaluation. A total of 52 insertions with interstitial needles were performed, of the 148 needles inserted, 119 (80.4%) were loaded. HRCTV D90% coverage mean was EQD2 5.4 Gy (0.5-10.6 Gy) higher for the course containing loaded interstitial needles, while no significant change was observed with regards to OAR doses. This improved coverage is in line with international standards which report 4.4-9.0 Gy.

Conclusion: WBCC's early experience of interstitial cervix brachytherapy has shown our target coverage improvements meet previously published international standards and confirms the value of this technique. This audit supports ongoing use of interstitial needles at the WBCC.

Keywords: brachytherapy; cervical cancer; high-risk clinical target volume; image-guided brachytherapy; interstitial needles.

PubMed Disclaimer

References

    1. Haie-Meder C, Pötter R, Van Limbergen E et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-45.
    1. Mahantshetty U, Sturdza A, Naga CH P et al. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: an experience from two institutions: clinical feasibility and outcome. Radiother Oncol 2019; 141: 123-9.
    1. Dimopoulos JCA, Lang S, Kirisits C et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phy 2009; 75: 56-63.
    1. Pötter R, Tanderup K, Kirisits C et al. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol 2018; 9: 48-60.
    1. Sturdza A, Pötter R, Fokdal LU et al. Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 2016; 120: 428-33.